ALKERMES | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.18B 349M 2025-03
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
ALKERMES USD 521.2M 121.39M 2025-06
Amgen USD 8.03B 782M 2025-06
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
J&J USD 38.47B 32.35B 2025-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Merck USD 8.01B 622M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
Otsuka Holdings JPY 407.5B 18.68B 2025-03
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06


ALKERMES Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.